Cargando…
Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
Background: It is well known that there is a close relationship between elevated androgen plasma levels and the ultrasound findings of stromal hypertrophy in polycystic ovary syndrome (PCOS). The objective of this study was to investigate the effects metformin on the hyperandrogenism and ovarian vol...
Autores principales: | Farimani Sanoee, Marzieh, Neghab, Nosrat, Rabiee, Soghra, Amiri, Iraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556752/ https://www.ncbi.nlm.nih.gov/pubmed/23358726 |
Ejemplares similares
-
Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome
Patients after Administration of Metformin Associated with
Improving Cardiovascular Risk Factors?
por: Gharakhani, Mohsen, et al.
Publicado: (2011) -
Association of Prx4, Total Oxidant Status, and Inflammatory Factors with Insulin Resistance in Polycystic Ovary Syndrome
por: Mazloomi, Sahar, et al.
Publicado: (2021) -
Ovarian Aging-Like Phenotype in the Hyperandrogenism-Induced Murine Model of Polycystic Ovary
por: Rezvanfar, Mohammad Amin, et al.
Publicado: (2014) -
Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021) -
The Association of Mitochondrial Translocator Protein and Voltage-Dependent Anion Channel-1 in Granulosa Cells with Estradiol Levels and Presence of Immature Follicles in Polycystic Ovary Syndrome
por: Mazloomi, Sahar, et al.
Publicado: (2022)